TerrAscend's wholly-owned subsidiary, Solace Health, launches the Solace Health Marketplace

/NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES/

TORONTO, April 25, 2018 /CNW/ - TerrAscend Corp. (CSE:TER) ("TerrAscend" or the "Company") is pleased to announce that its wholly-owned subsidiary, Solace Health Inc. ("Solace Health"), has launched the Solace Health Marketplace, a centralized destination for Canadian cannabis patients to access information, quality support and a diverse selection of dried cannabis products to support patient wellness.

The Solace Health Marketplace is a one-stop hub for medical patients to access information and support regarding the use of medical cannabis and offers cannabis products with varying cannabinoid and terpene profiles. The Solace Health Marketplace will also offer registered patients the ability to buy cannabis accessories, and a same-day delivery option for patients within the Greater Toronto Area, to support patients' journey to wellness. The Company has cultivated and sourced from strategic industry partners in excess of 1,000kg of dried cannabis, including more than 15 different genetic strains, to support its mandate of providing patients with a diverse selection of quality cannabis. 

"We are very excited to offer a single destination for patients to access a variety of cannabis products and connect with dedicated customer service representatives to support their path to wellness" noted Sabrina Ramkellawan, Vice President of Clinical Affairs at TerrAscend. "The Solace Health Marketplace aims to offer a variety of brands and products that address underserved segments of cannabis patients that require a quality, holistic service provider to support their use of medical cannabis."

The Solace Health Marketplace is accessible at www.SolaceHealth.com.

About TerrAscend
TerrAscend is a biopharmaceutical and wellness company that is committed to quality products, brands and services for the global cannabinoid market.  The Company provides support to medical consumers through its wholly-owned subsidiaries, Solace Health Inc., a licenced producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations and Terra Health Network Inc., a clinical support program and education platform led by healthcare professionals.

Forward Looking Information
This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements include, but are not limited to, the anticipated timing for closing of the Private Placement, and the anticipated use of proceeds of the Private Placement. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

SOURCE TerrAscend

regarding the Company: Ari Unterman, Investor Relations, 1-855-TERRA-95 x100, [email protected]; Michael Nashat, President and CEO, 1-855 TERRA-95, [email protected]